Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content
Mrc_logo colour_rgb non professional print 002.jpg

Welcome to the Oxford Institute for Radiation Oncology

 Director: Professor Amato Giaccia

The mission of the Oxford Institute for Radiation Oncology (OIRO) is to explore and utilise aspects of radiation biology research to improve the role radiation plays in cancer cure rates.

The Institute is critical to the research mission of Oxford’s Cancer Centre, cancer related activities and the NHS’s treatment of cancer.  We are applying a multi-disciplinary approach to enhance the efficacy of radiation, treat metastatic disease and accelerate patient throughput with AI and machine learning.  We are ideally positioned to make seminal and transformative contributions to both understanding basic mechanisms of radiation biology as well as enhancing therapeutic efficacy in the next 5–10 years.  We intend to exploit biological and technical advances which can enhance the impact of radiation treatment in curing cancer. This work is achieved, in part, from the generous support of the MRC.

As a world-leading centre dedicated to radiation oncology and biology, the Institute now has over 200 staff and postgraduate students - both clinical and non-clinical - and brings together research and clinical groups from a range of disciplines, including biology, chemistry, physics, medicine and computational biology.  

 The Institute sits within the Department of Oncology in the University of Oxford’s Medical Sciences Division with research groups based in the Old Road Campus Research Building, the Radiobiology Research Institute and the NHS Cancer and Haematology Centre.